TIDMAPGN TIDMBARC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 02 March 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
453,537 0.20% 1,902,235 0.84%
(2) Derivatives (other than options):
205,343 0.09% 30,257 0.01%
(3) Options and agreements to
purchase/sell: 24,200 0.01% 24,200 0.01%
TOTAL:
683,080 0.30% 1,956,692 0.87%
(b) Interests and short positions in relevant securities of the
company, other than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 231.9100 USD
Purchase 4 231.4600 USD
Purchase 8 233.4331 USD
Purchase 9 231.9500 USD
Purchase 18 232.5100 USD
Purchase 54 233.3029 USD
Purchase 65 231.7500 USD
Purchase 65 231.2100 USD
Purchase 85 232.4500 USD
Purchase 90 231.2650 USD
Purchase 99 232.3730 USD
Purchase 100 231.2000 USD
Purchase 100 231.1000 USD
Purchase 100 233.1000 USD
Purchase 100 232.4100 USD
Purchase 102 231.3968 USD
Purchase 150 231.5633 USD
Purchase 162 231.8256 USD
Purchase 166 231.3920 USD
Purchase 185 232.8291 USD
Purchase 200 233.5133 USD
Purchase 200 233.7875 USD
Purchase 200 232.7275 USD
Purchase 222 232.8566 USD
Purchase 260 231.0600 USD
Purchase 300 232.4333 USD
Purchase 300 231.5650 USD
Purchase 368 232.9500 USD
Purchase 404 232.6484 USD
Purchase 407 232.1163 USD
Purchase 420 232.3907 USD
Purchase 478 233.1272 USD
Purchase 537 234.1406 USD
Purchase 551 232.3760 USD
Purchase 586 232.7679 USD
Purchase 692 232.8150 USD
Purchase 717 232.4984 USD
Purchase 726 232.9328 USD
Purchase 985 232.9983 USD
Purchase 1,604 232.4424 USD
Purchase 1,738 232.4034 USD
Purchase 2,855 232.9601 USD
Purchase 3,137 233.1214 USD
Purchase 4,076 233.3474 USD
Purchase 5,233 232.7094 USD
Purchase 5,547 233.0504 USD
Purchase 5,723 233.1910 USD
Purchase 5,964 232.5826 USD
Purchase 6,404 232.5300 USD
Purchase 6,975 232.5958 USD
Purchase 7,130 233.1368 USD
Purchase 10,693 233.1201 USD
Purchase 26,055 232.9599 USD
Purchase 38,430 232.6110 USD
Sale 3 233.0050 USD
Sale 4 231.4600 USD
Sale 5 233.6900 USD
Sale 16 232.7200 USD
Sale 18 234.2766 USD
Sale 22 233.7400 USD
Sale 24 233.7800 USD
Sale 24 234.3700 USD
Sale 30 234.0115 USD
Sale 30 232.9200 USD
Sale 36 234.0745 USD
Sale 54 234.0584 USD
Sale 63 234.2047 USD
Sale 65 231.7500 USD
Sale 66 231.1300 USD
Sale 72 234.1925 USD
Sale 90 231.2650 USD
Sale 100 232.1900 USD
Sale 100 233.1300 USD
Sale 105 232.8731 USD
Sale 115 234.0960 USD
Sale 121 232.9661 USD
Sale 133 231.9027 USD
Sale 172 231.7452 USD
Sale 184 233.2097 USD
Sale 200 232.0700 USD
Sale 200 233.8600 USD
Sale 200 234.2625 USD
Sale 200 232.2500 USD
Sale 252 232.5663 USD
Sale 260 231.0600 USD
Sale 352 233.7940 USD
Sale 419 232.8206 USD
Sale 435 233.1733 USD
Sale 500 232.4450 USD
Sale 551 233.6046 USD
Sale 592 231.5664 USD
Sale 1,233 232.8103 USD
Sale 1,389 233.2366 USD
Sale 1,769 232.7720 USD
Sale 1,786 233.2180 USD
Sale 2,557 232.9500 USD
Sale 2,890 233.2892 USD
Sale 3,620 231.9735 USD
Sale 4,758 232.5390 USD
Sale 4,824 232.6976 USD
Sale 5,011 233.3305 USD
Sale 5,466 233.1422 USD
Sale 9,501 233.1869 USD
Sale 10,117 232.5300 USD
Sale 13,413 232.9535 USD
Sale 28,433 232.9134 USD
Sale 38,622 232.6266 USD
(b) Derivatives transactions (other than options
transactions)
Product name, Nature of transaction Number of relevant Price per unit
e.g. CFD (Note 6) securities (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant
securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option money
name, selling, securities price e.g. date paid/received
e.g. purchasing, to which American, per unit
call varying the option European (Note 5)
option etc. relates etc.
(Note 7)
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this
should be stated.
None
Is a Supplemental Form 8 (Open
Positions) attached? YES
Date of disclosure: 3 Mar 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of
offeree/offeror with which connected
If a connected EFM, state nature of
connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form
8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
relevant
purchased securities price date
to which the
option
or derivative
relates
Put Options Purchased -1,200 220.0000 American Jul 16, 2021
Call Options Purchased 1,200 240.0000 American Jul 16, 2021
Call Options Purchased 23,000 220.0000 American Jul 16, 2021
Put Options Purchased -23,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative
positions (except for CFDs), full details should be given. Full
details of any existing agreements to purchase or to sell must also
be given on this form.
2. For all prices and other monetary amounts, the currency must
be stated.
For full details of disclosure requirements, see Rule 8 of the
Rules. If in doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210303005569/en/
CONTACT:
BARCLAYS PLC
SOURCE: BARCLAYS PLC
Copyright Business Wire 2021
(END) Dow Jones Newswires
March 03, 2021 08:35 ET (13:35 GMT)
Applegreen (LSE:APGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applegreen (LSE:APGN)
Historical Stock Chart
From Apr 2023 to Apr 2024
